Sakar Healthcare Ltd Financials
Company Logo

Sakar Healthcare Ltd Financial Statement

Sakar Healthcare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue43.15
Operating Expense31.28
Net Profit4.80
Net Profit Margin11.12
Earning Per Share2.17
EBIDTA11.56
Effective Tax RateTBA

Sakar Healthcare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual153.35
Operating Expenses Annual114.99
Operating Profit Annual41.54
Interest Annual7.59
Depreciation18.05
Net Profit Annual11.67
Tax Annual4.23

Sakar Healthcare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.09
Cash Flow from Operations24.47
Cash Flow from Investing-51.54
Cash Flow from Financing27.44
Cash Flow at the End0.46

Sakar Healthcare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)27.09
PBIT Margin (%)15.32
PBT Margin (%)13.31
Net PROFIT Margin (%)7.61
Return On Networth / Equity (%)5.36
Return On Networth /Employed (%)7.36
Return On Assets (%)3.65
Total Debt / Equity (X)0.46
Asset Turnover Ratio (%)0.48

Sakar Healthcare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual314.29
Total Current Assets Annual71.69
Non Current Assets Annual317.06
Total Shareholders Funds Annual262.42
Total Assets Annual388.74

Sakar Healthcare Ltd Earning Calls

EPS (INR)

Expected

2.21

Reported

2.17

Surprise

-1.81%

Jun 2024

EPS beaten by -1.81%

Mar 2024

EPS beaten by -0.90%

Dec 2023

EPS beaten by 2.10%

Get Your FAQs Right

As of Nov 5, 2024, Sakar Healthcare Ltd has a market capitalization of 801.05 Cr. Value Research classifies it as a Small-Cap company.
Yes, Sakar Healthcare Ltd is debt-free with a debt-to-equity ratio of 0.26.
In FY 2023 , Sakar Healthcare Ltd recorded a total revenue of approximately 153.35 Cr marking a significant milestone in the company's financial performance.
Sakar Healthcare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.6% and 0.1% annually, respectively..
Sakar Healthcare Ltd's current PE ratio is 68.64.
Sakar Healthcare Ltd's ROCE averaged 8.4% from the FY ending March 2022 to 2024, with a median of 8.0%. It peaked at 10.1% in March 2022, reflecting strong capital efficiency over the period..
Sakar Healthcare Ltd's latest EBIT is Rs. 23.49 Cr, surpassing the average EBIT of Rs. 22.74 Cr over the 5 years..